Centene Corporation (CNC) EV/EBITDA Ratio: N/A
The EV/EBITDA ratio for Centene Corporation (CNC) is N/A as of Thursday, June 18, 2026.
CNC EV/EBITDA Ratio Chart
CNC Average EV/EBITDA Ratio Chart
CNC EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
4.99x
EV/EBITDA RATIO AVG 3Y
6.91x
EV/EBITDA RATIO AVG 5Y
9.49x
EV/EBITDA RATIO AVG 10Y
9.84x
EV/EBITDA RATIO AVG 15Y
9.97x
EV/EBITDA RATIO AVG 20Y
9.41x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
CNC Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Centene Corporation (CNC) | $29.94B | N/A | 4.99x | 6.91x | 9.49x |
| Medline Inc. (MDLN)vs › | $30.23B | 14.81x | 16.16x | 16.16x | 16.16x |
| Biogen Inc. (BIIB)vs › | $29.33B | 12.09x | 8.76x | 11.19x | 12.23x |
| IQVIA Holdings Inc. (IQV)vs › | $28.48B | 12.25x | 13.61x | 15.08x | 17.12x |
| Zoetis Inc. (ZTS)vs › | $32.39B | 9.91x | 15.48x | 20.59x | 23.68x |
| DexCom, Inc. (DXCM)vs › | $27.49B | 19.17x | 25.12x | 42.08x | 70.41x |
| Veeva Systems Inc. (VEEV)vs › | $25.15B | 18.40x | 32.90x | 43.73x | 53.78x |
| Agilent Technologies, Inc. (A)vs › | $35.12B | 18.79x | 21.06x | 21.69x | 23.06x |
| Moderna, Inc. (MRNA)vs › | $24.52B | N/A | 12.39x | 25.28x | 25.28x |
| BioNTech SE (BNTX)vs › | $23.32B | N/A | 51.40x | 19.63x | 20.05x |
Centene Corporation EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Centene Corporation EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Centene Corporation (CNC)?
- The EV/EBITDA ratio for CNC stock is N/A.
- What is the TTM average EV/EBITDA ratio for Centene Corporation (CNC)?
- The TTM average EV/EBITDA ratio for CNC stock is 4.99x.
- What is the 3Y average EV/EBITDA ratio for Centene Corporation (CNC)?
- The 3Y average EV/EBITDA ratio for CNC stock is 6.91x.
- What is the 5Y average EV/EBITDA ratio for Centene Corporation (CNC)?
- The 5Y average EV/EBITDA ratio for CNC stock is 9.49x.
- What is the 10Y average EV/EBITDA ratio for Centene Corporation (CNC)?
- The 10Y average EV/EBITDA ratio for CNC stock is 9.84x.
- What is the 15Y average EV/EBITDA ratio for Centene Corporation (CNC)?
- The 15Y average EV/EBITDA ratio for CNC stock is 9.97x.
- What is the 20Y average EV/EBITDA ratio for Centene Corporation (CNC)?
- The 20Y average EV/EBITDA ratio for CNC stock is 9.41x.
Centene Corporation EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2025-10-27 | 4.13x |
| 2025-10-24 | 4.23x |
| 2025-10-23 | 4.26x |
| 2025-10-22 | 4.43x |
| 2025-10-21 | 4.44x |
| 2025-10-20 | 4.39x |
| 2025-10-17 | 4.35x |
| 2025-10-16 | 4.39x |
| 2025-10-15 | 4.41x |
| 2025-10-14 | 4.48x |
| 2025-10-13 | 4.47x |
| 2025-10-10 | 4.41x |
| 2025-10-09 | 4.62x |
| 2025-10-08 | 4.69x |
| 2025-10-07 | 4.68x |
| 2025-10-06 | 4.60x |
| 2025-10-03 | 4.71x |
| 2025-10-02 | 4.52x |
| 2025-10-01 | 4.40x |
| 2025-09-30 | 4.40x |
| 2025-09-29 | 4.35x |
| 2025-09-26 | 4.31x |
| 2025-09-25 | 4.26x |
| 2025-09-24 | 4.29x |
| 2025-09-23 | 4.09x |
| 2025-09-22 | 4.08x |
| 2025-09-19 | 3.99x |
| 2025-09-18 | 4.03x |
| 2025-09-17 | 4.01x |
| 2025-09-16 | 3.99x |
| 2025-09-15 | 4.08x |
| 2025-09-12 | 4.14x |
| 2025-09-11 | 4.23x |
| 2025-09-10 | 3.93x |
| 2025-09-09 | 3.91x |
| 2025-09-08 | 3.68x |
| 2025-09-05 | 3.69x |
| 2025-09-04 | 3.66x |
| 2025-09-03 | 3.81x |
| 2025-09-02 | 3.76x |
| 2025-08-29 | 3.70x |
| 2025-08-28 | 3.63x |
| 2025-08-27 | 3.68x |
| 2025-08-26 | 3.66x |
| 2025-08-25 | 3.70x |
| 2025-08-22 | 3.74x |
| 2025-08-21 | 3.68x |
| 2025-08-20 | 3.74x |
| 2025-08-19 | 3.73x |
| 2025-08-18 | 3.69x |
| 2025-08-15 | 3.64x |
| 2025-08-14 | 3.48x |
| 2025-08-13 | 3.49x |
| 2025-08-12 | 3.40x |
| 2025-08-11 | 3.30x |
| 2025-08-08 | 3.34x |
| 2025-08-07 | 3.30x |
| 2025-08-06 | 3.30x |
| 2025-08-05 | 3.37x |
| 2025-08-04 | 3.40x |
| 2025-08-01 | 3.37x |
| 2025-07-31 | 3.39x |
| 2025-07-30 | 3.36x |
| 2025-07-29 | 3.33x |
| 2025-07-28 | 3.47x |
| 2025-07-25 | 3.63x |
| 2025-07-24 | 3.46x |
| 2025-07-23 | 2.81x |
| 2025-07-22 | 2.69x |
| 2025-07-21 | 2.65x |
| 2025-07-18 | 2.69x |
| 2025-07-17 | 2.78x |
| 2025-07-16 | 2.88x |
| 2025-07-15 | 2.85x |
| 2025-07-14 | 2.90x |
| 2025-07-11 | 2.96x |
| 2025-07-10 | 3.04x |
| 2025-07-09 | 3.09x |
| 2025-07-08 | 3.05x |
| 2025-07-07 | 3.09x |
| 2025-07-03 | 3.11x |
| 2025-07-02 | 3.14x |
| 2025-07-01 | 4.90x |
| 2025-06-30 | 4.72x |
| 2025-06-27 | 4.70x |
| 2025-06-26 | 4.67x |
| 2025-06-25 | 4.66x |
| 2025-06-24 | 4.70x |
| 2025-06-23 | 4.65x |
| 2025-06-20 | 4.73x |
| 2025-06-18 | 4.79x |
| 2025-06-17 | 4.77x |
| 2025-06-16 | 4.75x |
| 2025-06-13 | 4.79x |
| 2025-06-12 | 4.80x |
| 2025-06-11 | 4.80x |
| 2025-06-10 | 4.81x |
| 2025-06-09 | 4.83x |
| 2025-06-06 | 4.79x |
| 2025-06-05 | 4.76x |
| 2025-06-04 | 4.77x |
| 2025-06-03 | 4.80x |
| 2025-06-02 | 4.77x |
| 2025-05-30 | 4.89x |
| 2025-05-29 | 4.89x |
| 2025-05-28 | 4.85x |
| 2025-05-27 | 4.98x |
| 2025-05-23 | 4.88x |
| 2025-05-22 | 5.01x |
| 2025-05-21 | 5.22x |
| 2025-05-20 | 5.31x |
| 2025-05-19 | 5.28x |
| 2025-05-16 | 5.30x |
| 2025-05-15 | 5.16x |
| 2025-05-14 | 5.12x |
| 2025-05-13 | 5.08x |
| 2025-05-12 | 5.38x |
| 2025-05-09 | 5.37x |
| 2025-05-08 | 5.35x |
| 2025-05-07 | 5.38x |
| 2025-05-06 | 5.14x |
| 2025-05-05 | 5.14x |
| 2025-05-02 | 5.17x |
| 2025-05-01 | 5.11x |
| 2025-04-30 | 5.15x |
| 2025-04-29 | 5.10x |
| 2025-04-28 | 5.12x |
| 2025-04-25 | 4.98x |
| 2025-04-24 | 5.28x |
| 2025-04-23 | 5.89x |
| 2025-04-22 | 5.74x |
| 2025-04-21 | 5.56x |
| 2025-04-17 | 5.78x |
| 2025-04-16 | 5.88x |
| 2025-04-15 | 5.91x |
| 2025-04-14 | 5.97x |
| 2025-04-11 | 6.04x |
| 2025-04-10 | 5.92x |
| 2025-04-09 | 5.94x |
| 2025-04-08 | 5.92x |
| 2025-04-07 | 5.83x |
| 2025-04-04 | 5.88x |
| 2025-04-03 | 6.07x |
| 2025-04-02 | 5.78x |
| 2025-04-01 | 5.76x |
| 2025-03-31 | 5.78x |
| 2025-03-28 | 5.73x |
| 2025-03-27 | 5.74x |
| 2025-03-26 | 5.77x |
| 2025-03-25 | 5.64x |
| 2025-03-24 | 5.67x |
| 2025-03-21 | 5.63x |
| 2025-03-20 | 5.69x |
| 2025-03-19 | 5.66x |
| 2025-03-18 | 5.70x |
| 2025-03-17 | 5.66x |
| 2025-03-14 | 5.58x |
| 2025-03-13 | 5.56x |
| 2025-03-12 | 5.60x |
| 2025-03-11 | 5.61x |
| 2025-03-10 | 5.68x |
| 2025-03-07 | 5.73x |
| 2025-03-06 | 5.68x |
| 2025-03-05 | 5.64x |
| 2025-03-04 | 5.55x |
| 2025-03-03 | 5.61x |
| 2025-02-28 | 5.57x |
| 2025-02-27 | 5.58x |
| 2025-02-26 | 5.47x |
| 2025-02-25 | 5.83x |
| 2025-02-24 | 5.64x |
| 2025-02-21 | 5.54x |
| 2025-02-20 | 5.60x |
| 2025-02-19 | 5.53x |
| 2025-02-18 | 5.39x |
| 2025-02-14 | 5.57x |
| 2025-02-13 | 5.56x |
| 2025-02-12 | 5.53x |
| 2025-02-11 | 5.62x |
| 2025-02-10 | 5.75x |
| 2025-02-07 | 5.75x |
| 2025-02-06 | 5.73x |
| 2025-02-05 | 5.91x |
| 2025-02-04 | 5.96x |
| 2025-02-03 | 6.28x |
| 2025-01-31 | 6.21x |
| 2025-01-30 | 6.26x |
| 2025-01-29 | 6.20x |
| 2025-01-28 | 6.27x |
| 2025-01-27 | 6.37x |
| 2025-01-24 | 6.26x |
| 2025-01-23 | 6.30x |
| 2025-01-22 | 6.16x |
| 2025-01-21 | 6.17x |
| 2025-01-17 | 6.05x |
| 2025-01-16 | 6.10x |
| 2025-01-15 | 6.13x |
| 2025-01-14 | 6.15x |
| 2025-01-13 | 6.18x |
| 2025-01-10 | 6.01x |
| 2025-01-08 | 6.13x |
| 2025-01-07 | 6.08x |
| 2025-01-06 | 6.09x |
| 2025-01-03 | 5.98x |
| 2025-01-02 | 5.89x |
| 2024-12-31 | 5.90x |
| 2024-12-30 | 5.88x |
| 2024-12-27 | 5.90x |
| 2024-12-26 | 5.93x |
| 2024-12-24 | 5.92x |
| 2024-12-23 | 5.87x |
| 2024-12-20 | 5.81x |
| 2024-12-19 | 5.82x |
| 2024-12-18 | 5.80x |
| 2024-12-17 | 5.65x |
| 2024-12-16 | 5.77x |
| 2024-12-13 | 5.80x |
| 2024-12-12 | 5.67x |
| 2024-12-11 | 5.57x |
| 2024-12-10 | 5.56x |
| 2024-12-09 | 5.71x |
| 2024-12-06 | 5.56x |
| 2024-12-05 | 5.67x |
| 2024-12-04 | 5.83x |
| 2024-12-03 | 5.80x |
| 2024-12-02 | 5.85x |
| 2024-11-29 | 5.85x |
| 2024-11-27 | 5.84x |
| 2024-11-26 | 5.85x |
| 2024-11-25 | 5.98x |
| 2024-11-22 | 5.88x |
| 2024-11-21 | 5.88x |
| 2024-11-20 | 5.77x |
| 2024-11-19 | 5.65x |
| 2024-11-18 | 5.74x |
| 2024-11-15 | 5.62x |
| 2024-11-14 | 5.73x |
| 2024-11-13 | 5.67x |
| 2024-11-12 | 5.72x |
| 2024-11-11 | 5.91x |
| 2024-11-08 | 5.86x |
| 2024-11-07 | 6.07x |
| 2024-11-06 | 6.08x |
| 2024-11-05 | 6.28x |
| 2024-11-04 | 6.19x |
| 2024-11-01 | 6.16x |
| 2024-10-31 | 6.05x |
| 2024-10-30 | 6.01x |
| 2024-10-29 | 5.90x |
| 2024-10-28 | 5.99x |
| 2024-10-25 | 6.22x |
| 2024-10-24 | 5.99x |
| 2024-10-23 | 5.52x |
| 2024-10-22 | 5.63x |
| 2024-10-21 | 5.63x |
| 2024-10-18 | 5.72x |
| 2024-10-17 | 5.81x |
| 2024-10-16 | 6.39x |
| 2024-10-15 | 6.32x |
| 2024-10-14 | 6.73x |
Showing the most recent 260 of 4,863 data points. The chart above shows the full history.
Related Metrics
About Centene Corporation
Centene Corporation functions as a diverse, multinational healthcare organization, primarily dedicated to delivering a comprehensive range of programs and services to underinsured and uninsured individuals throughout the United States. Its Managed Care division provides extensive health plan coverage for people enrolled in various government-sponsored initiatives. These initiatives include Medicaid, the State Children's Health Insurance Program (SCHIP), long-term services and support, foster care, and specialized Medicare-Medicaid plans that cater to individuals dually eligible for both programs, as well as aged, blind, or disabled populations. The broad spectrum of benefits within these health plans encompasses primary and specialty physician care, inpatient and outpatient hospital services, emergency and urgent care, prenatal support, laboratory and X-ray diagnostics, and home-based primary care. Complementary services feature transportation assistance, vision and dental care, telehealth access, immunizations, specialty pharmacy, therapy, social work, nurse advisory support, and care coordination. Additionally, members are covered for prescriptions, limited over-the-counter medications, medical equipment, and essential behavioral health and substance abuse services. This segment also extends its offerings to commercial healthcare products for individuals and employer groups of various sizes. Centene's Specialty Services segment delivers a distinct set of solutions, including pharmacy benefits management (PBM), 24/7 nurse advice lines and after-hours support, vision and dental services, and staffing provisions for correctional systems and other government agencies. This division also serves beneficiaries eligible for the Military Health System. Its clientele for these specialized services spans state programs, correctional institutions, healthcare organizations, employer groups, and other commercial entities. The company delivers its healthcare services through an expansive network comprising primary and specialty care physicians, hospitals, and various ancillary providers. Established in 1984, Centene Corporation is headquartered in St. Louis, Missouri.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Sarah London